{
  "id": 18962340,
  "title": "Paul Gama, P&G CEO-health care, sells $477,510 in stock",
  "url": "https://urgent.news/2026/11/08/paul-gama-p-g-ceo-health-care-sells-477-510-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-08T15:01:11.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/paul-gama-pg-ceohealth-care-sells-477510-in-stock-93CH-5010248"
  },
  "original_language": "en",
  "account": "Procter & Gamble CEO Paul Gama sold $477,510 worth of the company's shares on October 30, 2026. He traded 2,894 shares at $165.00 each, leaving him with 43,898.8803 shares directly and 1,183.969 shares indirectly held through a retirement plan. Procter & Gamble has been busy in financial markets, issuing €3.25 billion in senior notes in four tranches maturing from 2030 to 2046 and a $4 billion offering extending to 2056. Analysts have revised their outlooks, with Piper Sandler and TD Cowen raising price targets to $167 and $166, respectively, citing strong performance. Morgan Stanley boosted its target to $185, highlighting 6% profit and earnings per share upside, as organic sales outpaced expectations by 4.0%.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}